Abstract
PSY22 - Cost analysis of Voriconazole versus Caspofungin for Primary Therapy of invasive Aspergillosis among High-Risk Hematologic Cancer Patients in China
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have